Mallinckrodt News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

14.05.18	Mallinckrodt To Present At Goldman Sachs 39th Annual Global Healthcare Conference (PR Newswire)
08.05.18	Mallinckrodt plc Reports First Quarter 2018 Results (PR Newswire)
07.05.18	Mallinckrodt Provides Facts on H.P. Acthar® Gel (PR Newswire)
04.05.18	FDA Panel Snubs MNK, Decision On AKCA Drug Delayed, PTLA's Antidote Greenlighted (RTTNews)
28.04.18	Previously Reported Data Security Incident - Customer Update and Instructions (PR Newswire)
28.04.18	Biotech Stocks Facing FDA Decision In May (RTTNews)
23.04.18	New Hampshire Purchasers/Lessees of New Vehicles and Purchasers of Certain Replacement Parts Now to Benefit from $1.04 Billion in Settlements (PR Newswire)
21.04.18	An Ear To The Pharma: 10 Stocks To Watch (BHVN, LLY, TOCA, ALDR…) (RTTNews)
20.04.18	Mallinckrodt To Present At UBS Global Healthcare Conference (PR Newswire)
16.04.18	Mallinckrodt plc Announces $300 Million Debt Repayment (PR Newswire)
09.04.18	Mallinckrodt To Present At Deutsche Bank's 43rd Annual Healthcare Conference (PR Newswire)
04.04.18	Mallinckrodt Names Paul R. Carter, Anne C. Whitaker to its Board of Directors (PR Newswire)
04.04.18	Angus Russell to Succeed Melvin Booth as Mallinckrodt Chairman of the Board in May 2018 (PR Newswire)
28.03.18	Biotech Stocks Facing FDA Decision In April (RTTNews)
28.03.18	Mallinckrodt plc To Report Earnings Results For The First Quarter Of Fiscal 2018 (PR Newswire)
26.03.18	Hilco Real Estate Announces The Sale Of A Prime 3,700 ± SF Office/Retail Building In Cathedral City, California (PR Newswire)
19.03.18	Mallinckrodt Completes Sale Of RECOTHROM® And PREVELEAK® To Baxter (PR Newswire)
15.03.18	Mallinckrodt Recognized as Manufacturing Leadership Awards 2018 Winner (PR Newswire)
27.02.18	Mallinckrodt Posting Significant Gain On Upbeat Q4 Results (RTTNews)
27.02.18	A Good Path Toward Better Work (PR Newswire)
27.02.18	Mallinckrodt plc Reports Fourth Quarter and Fiscal 2017 Results, Announces 2018 Guidance and Sets 2018 Strategic Priorities (PR Newswire)
26.02.18	KMPH Gets FDA Nod, ADMP On Track, OBSV To Report Data Today (RTTNews)
23.02.18	Mallinckrodt Receives FDA Acceptance of Stannsoporfin New Drug Application Filing (PR Newswire)
21.02.18	Mallinckrodt Earns Somerset County Planning Board Land Development Honor (PR Newswire)
15.02.18	Mallinckrodt To Present At Barclays Global Healthcare Conference (PR Newswire)
14.02.18	Mallinckrodt Enrolls First Patient in Phase 1 Study of ExpressGraft™C9T1 Skin Tissue (PR Newswire)
13.02.18	Mallinckrodt Completes Acquisition Of Sucampo Pharmaceuticals, Inc. (PR Newswire)
06.02.18	Boyd Gaming Set to Join S&P MidCap 400; Ring Energy, James River Group Holdings and EVERTEC to Join S&P SmallCap 600 (PR Newswire)
06.02.18	Mallinckrodt To Present At Raymond James 39th Annual Institutional Investors Conference (PR Newswire)
01.02.18	Mark Casey Joins Mallinckrodt as General Counsel (PR Newswire)
31.01.18	BLCM Plunges On Clinical Hold, Elite On Watch, VICL To Lay Off 54% Of Staff (RTTNews)
30.01.18	First Patient Enrolled in Mallinckrodt Phase 4 Trial of H.P. Acthar® Gel (Repository Corticotropin Injection) for Pulmonary Sarcoidosis (PR Newswire)
24.01.18	Industrial Enzyme Demand in Food and Beverages to Grow 4.5% Annually (PR Newswire)
08.01.18	Mallinckrodt To Sell Certain Hemostasis Products To Baxter (RTTNews)
08.01.18	Mallinckrodt Will Sell RECOTHROM® And PREVELEAK® To Baxter (PR Newswire)
05.01.18	EARS Down But Not Out, Major Event Awaits AMRN In Q3, Exciting Time For TTOO (RTTNews)
04.01.18	Mallinckrodt Completes Stannsoporfin New Drug Application Filing (PR Newswire)
02.01.18	Wolf Popper LLP Investigates the Proposed Acquisition of Sucampo Pharmaceuticals, Inc. by Mallinckrodt plc (PR Newswire)
26.12.17	Mallinckrodt Pulls Back Off Best Levels But Remains Positive (RTTNews)
26.12.17	Mallinckrodt To Buy Sucampo Pharma In $1.2 Bln Deal - Quick Facts (RTTNews)
26.12.17	Mallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 Billion (PR Newswire)
19.12.17	Mallinckrodt plc to Report Fourth Quarter and Full-Year 2017 Earnings Results on Feb. 27, 2018 (PR Newswire)
11.12.17	Mallinckrodt Completes Acquisition of Ocera Therapeutics and OCR-002, Its Proprietary Therapy in Development for Treatment of Hepatic Encephalopathy (PR Newswire)
04.12.17	Mallinckrodt plc Presents Health Economic Data on Management of Infantile Spasms at American Epilepsy Society Annual Meeting (PR Newswire)
22.11.17	Mallinckrodt In The Red Following Downgrade By Oppenheimer (RTTNews)
20.11.17	Chicago Rivet & Machine Co. Declares Dividend (PR Newswire)
16.11.17	Mallinckrodt plc Presents Health Economic Data on OFIRMEV® (acetaminophen) Injection at ASRA 16th Annual Pain Medicine Meeting (PR Newswire)
14.11.17	Mallinckrodt To Present At The BMO Prescriptions for Success Healthcare Conference (PR Newswire)
07.11.17	Mallinckrodt plc Reports Earnings Results for Third Quarter of Fiscal 2017 (PR Newswire)
02.11.17	Mallinckrodt To Acquire Ocera Therapeutics And OCR-002, Its Proprietary Therapy In Development For Treatment Of Hepatic Encephalopathy (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Mallinckrodt PLC

Aktien Top/Flop

Meistgelesene Nachrichten